Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anette Sommer

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Current Opinion in Drug Discovery & Development|October 29, 2003
Androgen receptor and prostate cancer: molecular aspects and gene expression profilingAnette Sommer, Bernard Haendler
Current Opinion in Drug Discovery & Development|June 26, 2004
Aspects of lung cancer gene expression profilingGerit Müller-Hagen, Thomas Beinert, Anette Sommer
Drug Discovery Today|December 14, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Drug Discovery Today|September 28, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Drug Discovery Today|December 7, 2010
Grants4Targets - an innovative approach to translate ideas from basic research into novel drugsMonika Lessl, Stefanie Schoepe, Anette Sommer, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 24, 2004
Novel molecular aspects of prostate carcinogenesisHellmuth-Alexander Meyer, Isabelle Ahrens-Fath, Anette Sommer, et al.
Cancer Cell International|January 20, 2012
5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosisFriedrich G Kapp, Anette Sommer, Thomas Kiefer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 12, 2003
Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell linesAnette Sommer, Jens Hoffmann, Rosemarie B Lichtner, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 10, 2009
Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification systemWiebke Afhüppe, Anette Sommer, Jörg Müller, et al.
International Journal of Oncology|September 3, 2009
Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer modelsTomke Ute Bracker, Anette Sommer, Iduna Fichtner, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Current Opinion in Drug Discovery & Development|October 29, 2003
Androgen receptor and prostate cancer: molecular aspects and gene expression profilingAnette Sommer, Bernard Haendler
Current Opinion in Drug Discovery & Development|June 26, 2004
Aspects of lung cancer gene expression profilingGerit Müller-Hagen, Thomas Beinert, Anette Sommer
Drug Discovery Today|December 14, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Drug Discovery Today|September 28, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Drug Discovery Today|December 7, 2010
Grants4Targets - an innovative approach to translate ideas from basic research into novel drugsMonika Lessl, Stefanie Schoepe, Anette Sommer, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 24, 2004
Novel molecular aspects of prostate carcinogenesisHellmuth-Alexander Meyer, Isabelle Ahrens-Fath, Anette Sommer, et al.
Cancer Cell International|January 20, 2012
5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosisFriedrich G Kapp, Anette Sommer, Thomas Kiefer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 12, 2003
Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell linesAnette Sommer, Jens Hoffmann, Rosemarie B Lichtner, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 10, 2009
Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification systemWiebke Afhüppe, Anette Sommer, Jörg Müller, et al.
International Journal of Oncology|September 3, 2009
Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer modelsTomke Ute Bracker, Anette Sommer, Iduna Fichtner, et al.
Pageof 4